Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127417241 | 12741724 | 1 | I | 20160318 | 20160905 | 20160914 | 20160914 | EXP | IT-SA-2016SA164854 | AVENTIS | 64.00 | YR | A | M | Y | 0.00000 | 20160914 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127417241 | 12741724 | 1 | PS | ENOXAPARIN SODIUM. | ENOXAPARIN SODIUM | 1 | Subcutaneous | DOSE: 8 IU IN THOUSAND DAILY | UNKNOWN | 20164 | 8 | IU | QD | ||||||
| 127417241 | 12741724 | 2 | SS | ENOXAPARIN SODIUM. | ENOXAPARIN SODIUM | 1 | Subcutaneous | DOSE: 8 IU IN THOUSAND DAILY | UNKNOWN | 20164 | 8 | IU | QD | ||||||
| 127417241 | 12741724 | 3 | SS | PREGABALIN. | PREGABALIN | 1 | Oral | U | UNKNOWN | 0 | 75 | MG | QD | ||||||
| 127417241 | 12741724 | 4 | SS | SORAFENIB | SORAFENIB | 1 | Oral | Y | UNKNOWN | 0 | 800 | MG | QD | ||||||
| 127417241 | 12741724 | 5 | SS | SORAFENIB | SORAFENIB | 1 | Oral | Y | UNKNOWN | 0 | 800 | MG | QD | ||||||
| 127417241 | 12741724 | 6 | SS | SORAFENIB | SORAFENIB | 1 | Oral | Y | 0 | 400 | MG | QD | |||||||
| 127417241 | 12741724 | 7 | SS | SORAFENIB | SORAFENIB | 1 | Oral | Y | 0 | 400 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127417241 | 12741724 | 1 | Thrombosis prophylaxis |
| 127417241 | 12741724 | 2 | Vena cava thrombosis |
| 127417241 | 12741724 | 4 | Hepatocellular carcinoma |
| 127417241 | 12741724 | 5 | Hepatocellular carcinoma |
| 127417241 | 12741724 | 6 | Hepatocellular carcinoma |
| 127417241 | 12741724 | 7 | Hepatocellular carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127417241 | 12741724 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127417241 | 12741724 | Hepatic encephalopathy | |
| 127417241 | 12741724 | Melaena |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127417241 | 12741724 | 1 | 20160219 | 0 | ||
| 127417241 | 12741724 | 2 | 20160219 | 0 | ||
| 127417241 | 12741724 | 3 | 20160219 | 0 | ||
| 127417241 | 12741724 | 4 | 20160306 | 20160318 | 0 | |
| 127417241 | 12741724 | 5 | 20160306 | 20160318 | 0 | |
| 127417241 | 12741724 | 6 | 20160323 | 20160406 | 0 | |
| 127417241 | 12741724 | 7 | 20160323 | 20160406 | 0 |